This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Web of Science (8) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Horsch, S. Articles by Hess, S. Search for Related Content PubMed PubMed Citation Articles by Horsch, S. Articles by Hess, S. Social Bookmarking                         What's this?

Spinal Cord Stimulation in the Treatment of Peripheral Vascular Disease: Results of a Single-Center Study of 258 Patients

Cologne, Germany, prof.horsch{at}khporz.de

Stefan Schulte, MD, PhD

Cologne, Germany

Stefan Hess, MD

Cologne, Germany

This report is of a retrospective study of data from 258 patients who received spinal cord stimulation (SCS) for the treatment of peripheral vascular disease as a result of arteriosclerosis. The patients’ clinical outcomes were monitored over a period of 18 months. In patients with a low baseline transcutaneous oxygen pressure (TcPO₂) value of <10 mm Hg, limb survival at 18 months of follow-up (estimated by use of Kaplan-Meier survival analysis) was 77.8%, and this was even higher, at 89.5%, in patients with a medium baseline TcPO₂ value of 10-30 mm Hg. This successful treatment was accompanied by a sustained increase in TcPO₂ values to approximately 30 mm Hg in both of these groups. In looking at diabetic and nondiabetic patients, there is no difference in limb survival as a result of the treatment. It is concluded that SCS is an effective therapy in improving limb survival in patients with peripheral vascular disease. In addition, TcPO₂ values at baseline may be a useful predictor of treatment outcome.

Angiology, Vol. 55, No. 2, 111-118 (2004)
DOI: 10.1177/000331970405500201


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?